These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 26607639)

  • 1. Exploring an increased role for Australian community pharmacy in mental health professional service delivery: evaluation of the literature
    Hattingh HL; Scahill S; Fowler JL; Wheeler AJ
    J Ment Health; 2016 Dec; 25(6):550-559. PubMed ID: 26607639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian mental health consumers and carers expect more health management information from community pharmacy.
    Fejzic J; Knox K; Hattingh HL; Mey A; McConnell D; Wheeler AJ
    Int J Pharm Pract; 2017 Dec; 25(6):454-462. PubMed ID: 28303618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using an intervention mapping framework to develop an online mental health continuing education program for pharmacy staff.
    Wheeler A; Fowler J; Hattingh L
    J Contin Educ Health Prof; 2013; 33(4):258-66. PubMed ID: 24347104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Australian mental health consumers' and carers' experiences of community pharmacy service.
    Knox K; Kelly F; Mey A; Hattingh L; Fowler JL; Wheeler AJ
    Health Expect; 2015 Dec; 18(6):2107-20. PubMed ID: 24612376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferences for the delivery of community pharmacy services to help manage chronic conditions.
    Whitty JA; Kendall E; Sav A; Kelly F; McMillan SS; King MA; Wheeler AJ
    Res Social Adm Pharm; 2015; 11(2):197-215. PubMed ID: 25116938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service.
    Maulavizada H; Emmerton L; Hattingh HL
    BMC Health Serv Res; 2016 Apr; 16():146. PubMed ID: 27112344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a person-centred community pharmacy mental health medication support service on consumer outcomes.
    McMillan SS; Kelly F; Hattingh HL; Fowler JL; Mihala G; Wheeler AJ
    J Ment Health; 2018 Apr; 27(2):164-173. PubMed ID: 28675321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trust and safe spaces: mental health consumers' and carers' relationships with community pharmacy staff.
    Mey A; Knox K; Kelly F; Davey AK; Fowler J; Hattingh L; Fejzic J; McConnell D; Wheeler AJ
    Patient; 2013; 6(4):281-9. PubMed ID: 24170278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative exploration of mental health services provided in community pharmacies.
    Crespo-Gonzalez C; Dineen-Griffin S; Rae J; Hill RA
    PLoS One; 2022; 17(5):e0268259. PubMed ID: 35551556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacy in Australia: a health hub destination of the future.
    McMillan SS; Wheeler AJ; Sav A; King MA; Whitty JA; Kendall E; Kelly F
    Res Social Adm Pharm; 2013; 9(6):863-75. PubMed ID: 23218552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the implementation of a novel community pharmacist-led support service for people living with severe and persistent mental illness.
    Ng R; El-Den S; Collins JC; Stewart V; McMillan SS; Hu J; Wheeler AJ; O'Reilly CL
    Res Social Adm Pharm; 2024 Jun; 20(6):113-122. PubMed ID: 38467520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intervention research to enhance community pharmacists' cognitive services: a systematic review.
    Patwardhan PD; Amin ME; Chewning BA
    Res Social Adm Pharm; 2014; 10(3):475-93. PubMed ID: 24071523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A national mailed survey exploring weight management services across Australian community pharmacies.
    Fakih S; Marriott JL; Hussainy SY
    Aust J Prim Health; 2015; 21(2):197-204. PubMed ID: 24594078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
    Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D
    Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
    Hanes CA; Wong KK; Saini B
    Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Australian community pharmacy services: a survey of what people with chronic conditions and their carers use versus what they consider important.
    McMillan SS; Kelly F; Sav A; King MA; Whitty JA; Wheeler AJ
    BMJ Open; 2014 Dec; 4(12):e006587. PubMed ID: 25488098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumers and Carers Versus Pharmacy Staff: Do Their Priorities for Australian Pharmacy Services Align?
    McMillan SS; Kelly F; Sav A; Kendall E; King MA; Whitty JA; Wheeler AJ
    Patient; 2015 Oct; 8(5):411-22. PubMed ID: 25512020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring oral healthcare management across Australian community pharmacies using case vignettes.
    Taing MW; Firth N; Ford PJ; Freeman CR
    Community Dent Oral Epidemiol; 2019 Jun; 47(3):225-235. PubMed ID: 30734359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurse practitioners: an insight into their integration into Australian community pharmacies.
    McMillan SS; Emmerton L
    Res Social Adm Pharm; 2013; 9(6):975-80. PubMed ID: 23062783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.